首页> 美国卫生研究院文献>EFSA Journal >Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 6: suitability of taxonomic units notified to EFSA until March 2017
【2h】

Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 6: suitability of taxonomic units notified to EFSA until March 2017

机译:通知EFSA 6的有意添加到食品或饲料中的QPS推荐生物制剂清单的更新:通知EFSA的生物分类单位是否适用至2017年3月

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The qualified presumption of safety ( ) concept was developed to provide a harmonised generic pre‐evaluation to support safety risk assessments of biological agents performed by 's scientific Panels. The identity, body of knowledge, safety concerns and antimicrobial resistance of valid taxonomic units were assessed. Safety concerns identified for a taxonomic unit are, where possible and reasonable in number, reflected as ‘qualifications’ which should be assessed at the strain level by the 's scientific Panels. No new information was found that would change the previously recommended taxonomic units and their qualifications. Between the end of September 2016 and March 2017, the notification list was updated with 87 applications for market authorisation. From these, 32 biological agents already had a status, and 37 were not included in the evaluation as they are filamentous fungi or enterococci. species (   and   (three notifications) and (seven notifications) were re‐confirmed not suitable for . and   , not evaluated within the previous mandate, were also not recommended for . spp. and  will be excluded from further evaluations within the current mandate. which has never been evaluated before, was not recommended for the list and for the assessment was not applicable because it is not a validated species. was a new taxonomic unit recommended to have the status.
机译:提出了合格的安全性推定()概念,以提供统一的通用预评估,以支持科学专家小组对生物制剂进行安全风险评估。评估了有效分类单位的身份,知识体系,安全性和抗菌素耐药性。对于分类单元确定的安全问题,在可能的情况下和合理的数量上应反映为“资格”,应由“科学小组”在菌株级别进行评估。没有发现新的信息会改变以前推荐的分类单位及其资格。在2016年9月底至2017年3月之间,通知列表更新了87个市场授权申请。从这些中,已经有32种生物制剂处于状态,并且由于它们是丝状真菌或肠球菌,因此没有包括37种。物种(和(三个通知)和(七个通知)已被重新确认为不适合。和,在以前的任务授权中未进行评估,也不推荐用于.spp。,并将被排除在当前任务授权的进一步评估之外。以前从未进行过评估,因此不建议用于该列表,也不建议进行评估,因为它不是经过验证的物种。

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号